ENGINE CAPITAL L.P. 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-22 12:40 pm Sale | 2020-06-19 | 13D | Harvard Bioscience, Inc. HBIO | ENGINE CAPITAL L.P. | 1,877,121 4.900% | -883,478 (-32.00%) | Filing |
| 2020-06-01 5:21 pm Sale | 2020-05-28 | 13D | Harvard Bioscience, Inc. HBIO | ENGINE CAPITAL L.P. | 2,760,599 7.200% | -448,891 (-13.99%) | Filing |
| 2020-04-06 5:02 pm Unchanged | 2020-04-06 | 13D | Harvard Bioscience, Inc. HBIO | ENGINE CAPITAL L.P. | 3,209,490 8.400% | 0 (Unchanged) | Filing |
| 2020-02-19 5:03 pm Unchanged | 2020-02-14 | 13D | Harvard Bioscience, Inc. HBIO | ENGINE CAPITAL L.P. | 3,209,490 8.400% | 0 (Unchanged) | Filing |